Bard® LifeStent® Vascular Stent Delivery System Study

Status Completed

Clinical Trial Summary

The purpose of this study is to evaluate the effectiveness and safety of a new delivery system for the Bard® LifeStent® Vascular Stent System.

Clinical Trial Description

Single-arm, non-randomized, prospective, multi-center study using the Bard® LifeStent® Vascular Stent Delivery System in subjects with lifestyle-limiting claudication or ischemic rest pain that are candidates for percutaneous transluminal angioplasty (PTA) and stenting with lesion(s) in the infra-inguinal segment (superficial femoral artery (SFA) and/or proximal popliteal artery). Subjects will be treated with PTA followed by implantation of the Bard® LifeStent® Vascular Stent.

Clinical follow-up for all subjects will be performed prior to hospital discharge, 30-days, and 12-, 24-, and 36-months post-index procedure. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01179984
Study type	Interventional
Source	C. R. Bard
Contact
Status	Completed
Phase	N/A
Start date	June 2010
Completion date	December 2013

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05335525` - Post-market Clinical Investigation of the Angio-Seal™ VIP VCD (ANGIO-SEAL CLOSE)
Active, not recruiting	`NCT01903044` - Safety and Efficacy of Autologous Bone Marrow Stem Cells for Lower Extremity Ischemia Treating	Phase 1/Phase 2
Completed	`NCT02271529` - Zilver PTX Delivery System	N/A
Completed	`NCT02228564` - BARD® Study of LIFESTREAM™ Balloon Expandable Covered Stent Treating Iliac Arterial Occlusive Disease	N/A
Recruiting	`NCT02054871` - RCT to Evaluate the Renal Protective Effects of Remote Ischaemic Preconditioning in Peripheral Angioplasty	N/A
Completed	`NCT00822172` - Evaluation of Cilostazol in Combination With L-Carnitine	Phase 4
Completed	`NCT00574782` - Evaluation of the Efficacy of Rosuvastatin in Daily Practice in Untreated High Risk Patients (CHALLENGE)	N/A
Completed	`NCT00029991` - Extract of Ginkgo Biloba (EGB 761) and Vascular Function	Phase 1/Phase 2
Completed	`NCT01355406` - Evaluation of Safety and Efficacy of the FlexStent® Femoropopliteal Self-Expanding Stent System	N/A
Recruiting	`NCT05804097` - Does Increasing Oxygen Nurture Your Symptomatic Ischemic Ulcer Sufficiently?	Phase 4
Recruiting	`NCT03638115` - The VaSecure BTK Study	N/A
Active, not recruiting	`NCT03241459` - Safety and Efficacy of the SurVeil™ Drug-Coated Balloon	N/A
Active, not recruiting	`NCT01661231` - Study to Determine the Performance of the Astron and Pulsar-18 Stents in Europe	N/A
Completed	`NCT01722877` - JetStream (JS) Atherectomy in Femoropopliteal In-Stent Restenotic Lesions	N/A
Completed	`NCT01444378` - Absolute Pro® MOMENTUM™	N/A
Completed	`NCT00753337` - The ACTIVE (Use of the Assurant® Cobalt Iliac Stent System in the Treatment of Iliac Vessel Disease) Study	N/A
Completed	`NCT00538226` - Evaluation of the Effect of the Flowaid Device in Increasing Local Circulation in the Leg	Phase 1
Completed	`NCT00593385` - Atrium iCAST Iliac Stent Pivotal Study	N/A
Recruiting	`NCT00385385` - RESTORE-IT-Study of Rifalazil in Chlamydia Pneumoniae Seropositive Patients With a History of Atherosclerotic Disease	Phase 2
Completed	`NCT00392509` - ALD-301 for Critical Limb Ischemia, Randomized Trial	Phase 1/Phase 2